Formulation and evaluation of novel coated floating tablets of bergenin and cetirizine dihydrochloride for gastric delivery
Authors:
- 30 December 2011
- journal article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 38 (10) , 1280-1288
Abstract
A novel coated gastric floating drug-delivery system (GFDDS) of bergenin (BN) and cetirizine dihydrochloride (CET) was developed. First, the pharmacodynamic studies were performed and the results revealed that the new compounds of bergenin/cetirizine dihydrochloride had comparative efficacy as commercial products (bergenin/chlorphenamine maleate) but with fewer side effects on central nervous system (CNS). Subsequently, bergenin was formulated as an extended-release core tablet while cetirizine dihydrochloride was incorporated into the gastric coating film for immediate release. The formulation of GFDDS was optimized by CET content uniformity test, in vitro buoyancy and drug release. Herein, the effects of sodium bicarbonate (effervescent), hydroxypropyl methylcellulose (HPMC, matrix polymer) and coating weight gain were investigated respectively. The optimized GFDDS exhibited good floating properties (buoyancy lag time < 2 min; floating duration > 10 h) and satisfactory drug-release profiles (immediate release of CET in 10 min and sustained release of BN for 12 h). In vivo gamma scintigraphy proved that the optimized GFDDS could retain in the stomach with a prolonged gastric retention time (GRT) of 5 h, and the coating layer showed no side effect for gastric retention. The novel coated gastric floating drug-delivery system offers a new approach to enhance BN’s absorption at its absorption site and the efficacy of both CET and BN.Keywords
This publication has 15 references indexed in Scilit:
- Optimization of acyclovir oral tablets based on gastroretention technology: Factorial design analysis and physicochemical characterization studiesDrug Development and Industrial Pharmacy, 2011
- A Case of Chlorpheniramine Maleate-Induced Hypersensitivity With Aspirin IntoleranceAllergy, Asthma & Immunology Research, 2011
- In Vitro Release Kinetics and Bioavailability of Gastroretentive Cinnarizine Hydrochloride TabletAAPS PharmSciTech, 2010
- Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: Development, optimization and in vitro–in vivo evaluation in healthy human volunteersEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Histamine and antihistaminesAnaesthesia & Intensive Care Medicine, 2008
- Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochlorideJournal of Pharmaceutical and Biomedical Analysis, 2005
- Gastroretentive Delivery Systems: A Mini ReviewDrug Development and Industrial Pharmacy, 2004
- Binding Characteristics of Cetirizine and Levocetirizine to Human H1Histamine Receptors: Contribution of Lys191and Thr194Molecular Pharmacology, 2002
- The comparative actions and adverse effect profile of single doses of H1-receptor antihistamines in the airways and skin of subjects with asthmaJournal of Allergy and Clinical Immunology, 1993
- Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis.1992